TOI — Oncology Institute Share News
0.000.00%
Last trade - 00:00- $525.91m
- $574.24m
- $502.73m
Brief: Oncology Institute Q1 Gross Profit USD 23.3 Million
Oncology Institute beats Q4 revenue estimates, net loss narrows
Brief: The Oncology Institute Reaffirms 2025 Guidance And Provides Preliminary 2026 Outlook
Brief: The Oncology Institute Announces Leadership Promotions
Brief: The Oncology Institute Announces Addition Of Board Member Mark Stolper
Brief: The Oncology Institute Announces Resignation Of Board Member Gabe Ling
Oncology Institute Q3 revenue jumps, partly on organic growth in Florida, Oregon
Brief: Oncology Institute Q3 Gross Profit USD 18.9 Million
Oncology Institute Inc reports results for the quarter ended June 30 - Earnings Summary
The Oncology Institute's Q2 revenue up 21.5%, beats estimates
Oncology Institute Inc expected to post a loss of 13 cents a share - Earnings Preview
Brief: Oncology Institute Files For Stock Shelf Of Upto $50 Million
Brief: Oncology Institute Q1 Revenue USD 9 Million
Brief: Oncology Institute Q3 Revenue USD 99.9 Million
Brief: The Oncology Institute Announces CFO Transition
Oncology Institute Inc reports results for the quarter ended in June - Earnings Summary
Brief: Oncology Institute Q2 Revenue USD 99 Million
Oncology Institute Inc expected to post a loss of 10 cents a share - Earnings Preview
Brief: Oncology Institute - On June 20, Got Notice From Nasdaq Indicating That Co Is No Longer In Compliance With Nasdaq Listing Rule 5550(A)(2)